Total Results: 7308
Matching with a residency program had an added layer of stress this year for doctors-in-training from the countries affected by President Donald Trump’s travel ban.
The HHS Secretary bought stock in companies that stood to benefit from legislation he voted for and sponsored as a Georgia congressman.
A cholesterol-lowering drug called Repatha cuts the risk of heart attacks, strokes and heart-related death by 20 percent, according to a new study.
Marathon, maker of an expensive treatment for Duchenne muscular dystrophy, sells the drug for $140 million in cash and stock to PTC Therapeutics.
The proposal would require manufacturers to give 90 days’ notice to purchasers before significantly increasing a drug’s price.
The numbers show that President Trump’s choice for FDA commissioner, Scott Gottlieb, has long-standing ties to pharmaceutical companies as a board member or consultant and that he had to recuse himself multiple times while working at the FDA.
For patients killed or maimed by medical errors, doctors and hospitals still often deny wrongdoing. But newer programs offering prompt disclosure of medical errors, an apology and compensation for them or their families are growing.
A new federal law requires that hospitals give Medicare patients notice after placing them under observation, along with the reason why they were not officially admitted. In California, it comes on top of a state law that requires quicker notice for all observation patients but does not oblige hospitals to explain their decision not to admit.
In the heated political arguments as Republicans rush to repeal and replace the Affordable Care Act, reality gets a bit lost.
A selection of opinions on health care developments from around the state.